Innovative Metabolics Raises $5.5M Series A Round

June 5, 2007 |

1 min read

Innovative Metabolics Inc., a developer of neuromodulation technology for chronic disease, has raised $5.5 million in Series A funding, investors in the round confirmed to VentureWire.

Startups

MORE ON THIS TOPIC

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Biogen Upends 20 Employees After Axing AAV Work

September 30, 2025

·

207 min read

·

BioSpace Editorial Staff

Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.

Series A

Novo-Backed Crystalys Debuts With $205M to Tackle Gout

September 30, 2025

·

2 min read

·

Tristan Manalac

Red Businesswoman Silhouette, Black Business People Group Team Concept Vector Illustration

Editorial

GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling

September 29, 2025

·

1 min read

·

Annalee Armstrong

GSK CEO Emma Walmsley

C-suite

GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years

September 29, 2025

·

4 min read

·

Annalee Armstrong